Navigation Links
Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016
Date:6/25/2012

FARMINGTON, Conn., June 25, 2012 /PRNewswire-iReach/ -- The enzyme inhibitors industry in emerging markets has significant potential, in contrast to mature markets where growth is significantly slower. Having accurate market data and analysis is essential to companies that wish to compete on the global stage. With premium market research from the world's leading publishers, Global Information Inc. helps businesses stay on the cutting edge with the best forecasts, research, and analyses.

(Photo: http://photos.prnewswire.com/prnh/20120625/CG29914)

Global Information is pleased to announce the immediate availability of three significant new reports on Enzyme Inhibitors.

Global Markets for Enzyme Inhibitors -- Focus on Europe

Global Markets for Enzyme Inhibitors -- Focus on US

Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets

The overall goal of this series is to provide a comprehensive understanding of the current and future characteristics for enzyme inhibitors, which include proton pump inhibitors (PPIs), protease inhibitors, reverse transcriptase inhibitors, kinase inhibitors, statins, aromatase inhibitors, phosphodiesterase type 5 (PDE5) inhibitors, neuraminidase inhibitors, and angiotensin-converting enzyme (ACE) inhibitors.

Each report offers Market sizes with 5-year forecasts from 2011 to 2016 for enzyme inhibitors in the pharmaceutical and biotechnology industry. These include market projections and market shares as well as a technology SWOT analysis.

Du
'/>"/>

SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Increasing Incidence of Cardiovascular Diseases to Drive The Cardiovascular Devices Market in Emerging Countries
2. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
3. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
4. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
5. Emerging Trends in Medical Device Outsourcing and Contract Manufacturing
6. Post-Recession, the Global Market for Surgical Equipment Picks Up Speed, Particularly In China and Emerging Economies
7. MD+DI, MPMN, Qmed and CMDM Announce Emerging Trends in Medical Device
8. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
9. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
10. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
11. MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Novation, the leading health care supply ... new IT value-added reseller (VAR) national contracts that ... IT goods and services at lower costs. These ... as value-added services such as initiative assistance and ... Novation agreements were awarded to CDW Government, Paragon ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ... dermatology for clinical and aesthetic dermatology practitioners in the ...
(Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very ... Mark King as its new Chief Executive Officer.  ... Operating Officer, in which he has overseen the company,s ... Mississippi , and Costa Rica.  Mr. King ... broad-based operations, sales, engineering and manufacturing experience in medical ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... With 30 Installed Inveon Imaging Systems, Siemens ... Position in Preclinical Imaging Centers, HOFFMAN ... adage,says "a picture is worth 1,000 words," ... research where high-resolution images can validate years ...
... Results Seen Since Presentation ... to Include Alvespimycin Plus Trastuzumab Plus ... Paclitaxel Regimen, HAYWARD, ... data from a Phase 1 clinical,trial showing that alvespimycin, its second-generation Hsp90 ...
Cached Medicine Technology:Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 2Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 3Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 4Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 5Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 2Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 3Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 4Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial 5
(Date:4/16/2014)... Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that ... CDX-1401 in solid tumors, including long-term patient follow-up, ... (Vol 6 Issue 232). The data demonstrate ... of clinical benefit in patients with very advanced ... to better outcomes on subsequent therapy with checkpoint ...
(Date:4/16/2014)... According to a new study, endoscopists, recommendations for ... to two small polyps are consistent with guideline recommendations ... an appropriate target for quality indicators. This is the ... guidelines for timing of repeat colonoscopy after one to ... average-risk patients. The study appears in the April issue ...
(Date:4/15/2014)... diabetes and pre-diabetes in the United States have nearly ... Hopkins Bloomberg School of Public Health, with obesity apparently ... that the burden of the disease has not hit ... blacks, Hispanics and the elderly. , According to new ... the Annals of Internal Medicine , diabetes increased ...
(Date:4/15/2014)... decades-old medical mystery and in the process have found ... which kill about 1.5 million people a year. The researchers ... an antifungal drug that has been in use for more ... toxic to human cells as it is to the microbes ... findings appears in Nature Chemical Biology . , "Invasive ...
(Date:4/15/2014)... Diego School of Medicine have identified a mechanism that ... liver disease and why the virus is able to ... The hard-to-kill pathogen, which infects an estimated 200 million ... the mitochondria dismantling the cell,s innate ability to ... dynamics. , The study, published in today,s issue of ...
Breaking Medicine News(10 mins):Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Breaking bad mitochondria 2
... CHAPEL HILL, N.C., Nov. 2 With ... the manufacturing environment, best-in-class,companies continue to focus ... internal and external customer relationships. In reviewing,the ... more,than three-quarters of the benchmark class posts ...
... 2 Addressing more than,100 cardiologists and other ... and CEO, set out four critical priorities for,improving ... at,Schering-Plough,s fourth annual Cardiovascular Summit in advance of ... In his speech, Hassan emphasized the potential for ...
... Hair to Help ... Women with Cancer, CINCINNATI, Nov. 2 Two-time Oscar winner,Hilary ... of support for women with cancer. This national campaign,encourages people to ... create free wigs for women who have lost their hair due ...
... Recent outbreaks of,antibiotic-resistant Staphylococcus aureus, more commonly known as ... healthy people,can carry on the skin or nose, it is ... the skin, in the blood, in the bones and,in the ... of antibiotics.,While most of these infections are minor, some however, ...
... Icon Supports Bargaining for Improved Patient Care, HUNTINGTON ... and co-founder of the United Farm Workers of,America, will ... Park for a walkthrough to shed light on patient ... year, caregivers have been seeking a new contract at,the ...
... Technique just as effective in patients under 60, study finds ... known as brachytherapy, are just as effective for treating prostate ... older men, a new study finds. , Brachytherapy is ... placed in the prostate to kill cancer cells. Recovery time ...
Cached Medicine News:Health News:Manufacturing Organizations Identify Efficiencies in Credit and Collections Functions 2Health News:Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment 2Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 2Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 3Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 4Health News:Radiation Seed Treatment Helps Younger Men Fight Prostate Cancer 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... part of the Freedom Urinary Collection ... bags, kits, and accessories designed to ... customers. These leg bags are offered ... 100% latex-free soft, textured medical grade ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
Medicine Products: